Janssen Global Services, a member of Johnson & Johnson’s family of companies, is recruiting for a Global Medical Affairs Leader (GMAL) - Rheumatology, to be located in Horsham, PA or Titusville, NJ.

At the Janssen Pharmaceutical Companies of Johnson & Johnson, what matters most is helping people live full and healthy lives. We focus on treating, curing and preventing some of the most devastating and complex diseases of our time. And we pursue the most promising science, wherever it might be found.

We are Janssen. Our mission drives us. Our patients inspire us. We collaborate with the world for the health of everyone in it.

The Global Medical Affairs Leader (GMAL) – Rheumatology will:

•Be responsible for leading the clinical-commercial optimization of product development and life cycle management strategies and plans for the assigned marketed compounds and compounds in clinical development within the Immunology TA.

•Be a member of the Compound Development Teams, the Safety Management Teams and Global Commercial Teams, Labelling working group, as well as an ad hoc member of the Clinical Team and Global Market Access Team and will be responsible for development of the global medical affairs plan that reflects prioritized regional needs and which are included in the overall Compound Development Plan.

•Be accountable for the global publications plans, global opinion leader relations, global medical education (including symposia, speaker training) and global advisory boards for products starting in early development (phase IIA) and through launch of major life cycle management initiatives (earlier or later as needed).

•Be an active member of the CDT and will lead a global Medical Affairs TA Team consisting of regionally designated Therapeutic Area Medical Affairs Leaders to create one medical affairs perspective and one “unified” voice on the CDT.

•Collaborate closely with the regional medical affairs representatives to develop integrated global medical affairs strategies and plans and maintain open, two-way communication to ensure regional medical affairs is up to date on all plans, progress, and decisions

•Be responsible for the development and execution of the global publication plan as well as review and approval of publications for marketed products and specified compounds in clinical development

•Support development of the Company risk management strategy and plan as well as author and review specific sections of the Periodic benefit-risk assessment report for compounds. Perform Medical impact assessments as required.

•A minimum of a MD or equivalent degree is required with specialty training and certification in rheumatology is preferred

•A minimum of 10 years of combined relevant experience in a medical/clinical environment and/or scientific function in the pharmaceutical industry is required, with a minimum of 5 years in the Medical Affairs environment preferred.